Prevalence of diabetes and diabetic macular edema in patients undergoing senile cataract surgery in Italy: The DIabetes and CATaract study
- PMID: 30854895
- PMCID: PMC7079292
- DOI: 10.1177/1120672119830578
Prevalence of diabetes and diabetic macular edema in patients undergoing senile cataract surgery in Italy: The DIabetes and CATaract study
Abstract
Background: The purpose of this study is to determine the prevalence of diabetes and diabetic macular edema in patients undergoing senile cataract surgery in Italy.
Methods: It is a prospective, multicenter, cross-sectional study. Thirteen ophthalmic units equally distributed across the Italian territory have been involved in the study. For a period of 3 months, all subjects undergoing phacoemulsification received an Optical Coherence Tompgraphy (OCT) scan and were screened for the anamnestic presence of diabetes. In addition, five selected units collected blood samples from all their patients to measure glycated hemoglobin (HbA1c) levels and detect the presence of occult diabetes (HbA1c > 6.5%). In diabetic patients, levels of retinopathy were measured and diabetic macular edema was considered significant (clinically significant macular edema) when foveal thickness was above 30% of normal levels.
Results: A total number of 3657 subjects have been screened. Among them, 20.4% were diabetics. Prevalence of diabetes was significantly higher in males (24.7%) than in females (17%). Levels of HbA1c were tested in a representative sample of 1216 consecutive subjects, and occult diabetes was diagnosed in 4.8% of cases. No significant differences were observed between age groups or different geographic areas. Among diabetic patients, diabetic macular edema of any kind was present in 27.5% (clinically significant macular edema (6.6%)). No significant differences were seen in the prevalence of diabetic macular edema between males and females or between age groups. Among the 745 diabetic patients, no signs of retinopathy were seen in 537 subjects (76.3%), while 101 patients (14.3%) had nonproliferative retinopathy, 13 (1.7%) had nontreated proliferative diabetic retinopathy, and 53 (7.5%) had laser-treated retinopathy. In the entire sample of 3657 subjects, a normal macula was present in 90.9% of cases, diabetic macular edema of any kind in 5.4%, and other maculopathies in 3.4%.
Conclusion: In this large cohort study on patients undergoing cataract surgery, more than one-fourth were diabetics and more than one-fourth of these had diabetic macular edema. These high prevalences suggest the opportunity to plan an adequate preoperative assessment in all patients in order to reduce the risk of postoperative development or worsening of a sight-threatening complication such as chronic diabetic macular edema.
Keywords: Diabetes; cataract; cataract surgery; diabetic macular edema; diabetic retinopathy; phacoemulsification.
Conflict of interest statement
Figures

Similar articles
-
Optimizing treatment for diabetic macular edema during cataract surgery.Front Endocrinol (Lausanne). 2023 Jan 25;14:1106706. doi: 10.3389/fendo.2023.1106706. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 36761187 Free PMC article. Review.
-
Diabetes and diabetic retinopathy in patients undergoing cataract surgery: a prevalence study-DiCat study report #2.Acta Diabetol. 2020 Jun;57(6):645-650. doi: 10.1007/s00592-019-01466-8. Epub 2020 Jan 7. Acta Diabetol. 2020. PMID: 31912329
-
Effect of combined cataract surgery and ranibizumab injection in postoperative macular edema in nonproliferative diabetic retinopathy.Retina. 2014 Jan;34(1):149-56. doi: 10.1097/IAE.0b013e3182979b9e. Retina. 2014. PMID: 23807186 Clinical Trial.
-
Analysis of macular edema after cataract surgery in patients with diabetes using optical coherence tomography.Ophthalmology. 2007 May;114(5):881-9. doi: 10.1016/j.ophtha.2006.08.053. Epub 2007 Feb 1. Ophthalmology. 2007. PMID: 17275910
-
Cataract Surgery Considerations for Diabetic Patients.Curr Diab Rep. 2021 Dec 30;21(12):67. doi: 10.1007/s11892-021-01418-z. Curr Diab Rep. 2021. PMID: 34967932 Review.
Cited by
-
Clinical efficacy of femtosecond laser-assisted phacoemulsification in diabetic cataract patients.World J Clin Cases. 2024 Apr 6;12(10):1733-1741. doi: 10.12998/wjcc.v12.i10.1733. World J Clin Cases. 2024. PMID: 38660074 Free PMC article.
-
Optimizing treatment for diabetic macular edema during cataract surgery.Front Endocrinol (Lausanne). 2023 Jan 25;14:1106706. doi: 10.3389/fendo.2023.1106706. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 36761187 Free PMC article. Review.
-
Three versus five intravitreal aflibercept injections as the initial loading phase in the treatment of diabetic macular edema: one-year results.Arq Bras Oftalmol. 2020 Sep-Oct;83(5):396-401. doi: 10.5935/0004-2749.20200078. Arq Bras Oftalmol. 2020. PMID: 33084817 Free PMC article. Clinical Trial.
-
Macular Edema and Visual Acuity Observation after Cataract Surgery in Patients with Diabetic Retinopathy.J Healthc Eng. 2022 Jan 25;2022:3311751. doi: 10.1155/2022/3311751. eCollection 2022. J Healthc Eng. 2022. PMID: 35126918 Free PMC article.
-
Intravitreal DEX Implant for the Treatment of Diabetic Macular Edema: A Review of National Consensus.Pharmaceutics. 2023 Oct 13;15(10):2461. doi: 10.3390/pharmaceutics15102461. Pharmaceutics. 2023. PMID: 37896220 Free PMC article. Review.
References
-
- Bourne RR, Stevens GA, White RA, et al. Causes of vision loss worldwide, 1990–2010: a systematic analysis. Lancet Glob Health 2013; 1(6): e339–e349. - PubMed
-
- Pascolini D, Mariotti SP. Global estimates of visual impairment: 2010. Br J Ophthalmol 2012; 96(5): 614–618. - PubMed
-
- Pershing S, Morrison DE, Hernandez-Boussard T. Cataract surgery complications and revisit rates among three states. Am J Ophthalmol 2016; 171: 130–138. - PubMed
-
- Jaycock P, Johnston RL, Taylor H, et al. The Cataract National Dataset electronic multi-centre audit of 55,567 operations: updating benchmark standards of care in the United Kingdom and internationally. Eye 2009; 23(1): 38–49. - PubMed